01 8Gowling WLG (Canada) LLP
02 3Smart & Biggar LLP
01 52632466
02 52689663
03 12799928
01 5RUXOLITINIB PHOSPHATE
02 6Ruxolitinib phosphate
01 3CREAM
02 2TABLET
03 6Tablet
01 11931-05-20
02 52026-12-12
03 52028-06-12
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Brand Name : JAKAVI
Patent Number : 2632466
Filing Date : 2006-12-12
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Brand Name : JAKAVI
Patent Number : 2632466
Filing Date : 2006-12-12
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Brand Name : JAKAVI
Patent Number : 2632466
Filing Date : 2006-12-12
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Brand Name : JAKAVI
Patent Number : 2632466
Filing Date : 2006-12-12
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Brand Name : JAKAVI
Patent Number : 2689663
Filing Date : 2008-06-12
Strength per Unit : 5 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Brand Name : JAKAVI
Patent Number : 2689663
Filing Date : 2008-06-12
Strength per Unit : 15 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Brand Name : JAKAVI
Patent Number : 2689663
Filing Date : 2008-06-12
Strength per Unit : 20 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Brand Name : JAKAVI
Patent Number : 2689663
Filing Date : 2008-06-12
Strength per Unit : 10 mg
Dosage Form : TABLET
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Brand Name : OPZELURA
Patent Number : 2632466
Filing Date : 2006-12-12
Strength per Unit : 1.5% W / W
Dosage Form : CREAM
Human Or VET : Human
Route of Administration : TOPICAL
Patent Expiration Date : 2026-12-12
Date Granted : 2013-09-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Brand Name : OPZELURA
Patent Number : 2689663
Filing Date : 2008-06-12
Strength per Unit : 1.5% W / W
Dosage Form : CREAM
Human Or VET : Human
Route of Administration : TOPICAL
Patent Expiration Date : 2028-06-12
Date Granted : 2016-08-09
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
